An SE vascular stent system has received approval from the US Food and Drug Administration to treat peripheral arterial disease in the iliac arteries and major blood vessels. The Complete SE Vascular Stent System, developed by Medtronic, treats peripheral arterial disease within the pelvis that supplies blood to the lower extremities. The system allows accurate stent placement in the iliacs, reducing the likelihood of stent ‘jumping,’ which is commonly seen during deployment with the use of many self-expanding stent systems. The Complete SE Vascular Stent System is made up of an inner shaft and features an innovative dual-deployment delivery system with a unique triaxial design. The device has been approved based on a study led by Dr Molnar and New York-Presbyterian Hospital/Columbia University Medical Center director of endovascular intervention William Gray. Patients are also enrolled in two additional trials investigating the use of the Complete SE stent for the treatment of superficial femoral artery stenoses and the balloon-expandable Assurant Cobalt stent in treating iliac artery disease.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.